Altered Gut Microbiota and Short-Chain Fatty Acids After Vonoprazan-Amoxicillin Dual Therapy for Helicobacter pylori Eradication

Altered Gut Microbiota and Short-Chain Fatty Acids After Vonoprazan-Amoxicillin Dual Therapy for Helicobacter pylori Eradication

The combination of vonoprazan (VPZ) and amoxicillin (VA therapy) has been shown to achieve acceptable eradication rates for Helicobacter pylori (H. pylori). Herein, our aim was to explore the short-term effect of VA therapy on the gut microbiota and short-chain fatty acids (SCFAs) using human fecal...

Full description

Bibliographic Details
Main Authors: Yi Hu, Xin Xu, Yao-Bin Ouyang, Cong He, Nian-Shuang Li, Chuan Xie, Chao Peng, Zhen-Hua Zhu, Xu Shu, Yong Xie, Nong-Hua Lu, Yin Zhu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Helicobacter pylori
eradication
vonoprazan
amoxicillin
gut microbiota
short-chain fatty acids
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2022.881968/full

Internet

https://www.frontiersin.org/articles/10.3389/fcimb.2022.881968/full

Similar Items